Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical benefits: fixed beam line vs gantry? PD Dr. Alexandra Jensen, MSc mingham-Why-send-tourists-there.html.

Published bySolomon Greene Modified over 8 years ago

Similar presentations

Presentation on theme: "Clinical benefits: fixed beam line vs gantry? PD Dr. Alexandra Jensen, MSc mingham-Why-send-tourists-there.html."— Presentation transcript:

1 Clinical benefits: fixed beam line vs gantry? PD Dr. Alexandra Jensen, MSc http://www.telegraph.co.uk/travel/destinations/europe/uk/11321943/Bir mingham-Why-send-tourists-there.html

2 Particle Therapy - Rationale according to Hermann Holthusen, 1933

3 Particle Therapy: SOBP http://www.umcutrecht.nl/getmedia/2ea49ddf-0390-4f1b-8c2a- b90b9166944c/mriProton1.jpg.aspx

4 Particle Treatment Delivery Systems http://www.dattoli.com/wp-content/uploads/2014/05/protons_diagram.jpg

5 Passive scattering: Range modulation https://www.helmholtz- berlin.de/media/media/angebote/pt/strahlentherapie/infos/modulatorrad_freig estellt.jpg

6 Urie et al, PMB 1984 Passive Beam Shaping http://www.oncolink.org/treatment/article.cf m?c=186&id=438

7 inhomogeneity compensation field collimation  range modulators (slide: Prof. O Jäkel) Passive Beam Shaping

8 Dose conformation only at distal end High dose region SOBP has a fixed extension Only measured depth doses needed No detailled biological modelling needed (slide: Prof. O Jäkel) Passive Beam Shaping

9 Active scanning techniques (Dept of Radiation Oncology, Heidelberg)

10 Intensity-controlled raster- scanning (Dept of Radiation Oncology, Heidelberg)

11 Intensity-controlled raster- scanning

12 Particle Therapy: fixed beam vs gantry beam application – passive beam application – active beam application spot scanning raster scanning IMPT fixed beam line – horizontal – oblique

13 Cozzi et al, Strahlenther Onkol 2006 60 Gy 54 Gy 50 Gy passive scatter spot scanningpassive scatter

14 Cozzi et al, Strahlenther Onkol 2006

15 Particle Therapy: fixed beam vs gantry scanning techniques vs passive beam application: – higher plan conformality – even in presence of gantry Cozzi et al, Strahlenther Onkol 2006

16 Jäkel et al, PMB 2000 Particle Therapy: fixed beam vs gantry Gantry at 65° and 300°horizontal beam line

17 Jäkel et al, PMB 2000 Particle Therapy: fixed beam vs gantry raster-scanning technique no IMPT improved conformality improved sparing of critical structures fixed oblique beam as lower cost alternative?

18 Kosaki et al, Radiat Oncol 2012 Particle Therapy: fixed beam vs gantry IMRTprotons, fixed beamprotons, gatry IMPT

19 Cao et al, Cancers 2015 IMPT, 2 horizontal beams Particle Therapy: fixed beam vs gantry IMPT, 3 beams, gantry

20 Cao et al, Cancers 2015 Particle Therapy: fixed beam vs gantry

21 Suzuki et al, Med Phys 2011 Particle Therapy: fixed beam vs gantry

22 Suzuki et al, Med Phys 2011 Particle Therapy: fixed beam vs gantry

23 N=4332 cases feasibility of gantry-less treatment? Yan et al, IJROBP 2015 FixedBend: +/- 20° Move: >+/-20° passive scattering head&neck44%70%100% torso99%100% scanning99%100%

24 Miralbell et al, IJROBP 2002 3D photonsIMRT photonsprotons Particle Therapy: fixed beam vs gantry

25 Dr. Nikoghosyan/ Dept Radiation Oncology Heidelberg

26 Uhl et al, Cancer J 2014 Particle Therapy: fixed beam vs gantry

27 SiteCountryStartParticleGantry Fixed horizontalOblique MoscowRussia1969p1 St PetersburgRussia1975p1 ClatterbridgeUK1989p1 Loma LindaUS1990p31 NiceFrance1991p1 OrsayFrance1991p11 iThembaSouth Africa1993p1 San FranciscoUS1994p1 VancouverCanada1995p1 BerlinGermany1998p1 DubnaRussia1999p1 HIBMCJapan2001p/C111 CataniaItaly2002p1 ShizupkaJapan2003p31 WanjieChina2004p21 WanzonChina2006C1 JacksonvilleUS2006p31 IlsanSouth Korea2007p21 OklahomaUS2009p111 GunmaJapan2010C31 ChicagoUS2010p112 HamptonUS2010p41 KrakowPoland2011p1 St LouisUS2013p1 YokohamaJapan2015C41 Jacksonville/ Ackermann CentreUS2015p1 http://ptcog.ch/index.php/facilities-in-operation

28 SiteCountryStartParticleScanningGantry Fixed horizontalOblique PSISwitzerland1984ps21 ChibaJapan1994Cs11 KashiwaJapan1998ps2 TsukubaJapan2001ps2 BostonUS2001ps21 BloomingtonUS2004ps21 HoustonUS2006ps31 KoriyamaJapan2008ps21 MunichGermany2009ps41 HeidelbergGermany2009p/Cs12 PhaldelphiaUS2010ps41 IbusukiJapan2011ps3 FukuiJapan2011ps21 PaviaItaly2011p/Cs31 PragueCzech Republik2012ps31 New JerseyUS2012ps4 EssenGermany2013ps41 NagoyaJapan2013ps21 SeattleUS2013ps4 ShanghaiChina2014p/Cs3 DresdenGermany2014ps1 TrentoItaly2014ps21 KnoxvilleUS2014ps3 San DiegoUS2014ps32 ShewportUS2014ps1 MarburgGermany2015p/Cs31 UppsalaSweden2015ps21 TaipeiTaiwan2015ps41 IrvingUS2015ps21 MemphisUS2015ps21 http://ptcog.ch/index.php/facilities-in-operation

29 Particle Therapy: fixed beam vs gantry dosimetric advantages of scanning techniques theoretical advantages of gantry arrangements gantry-less treatment reproducible with – positioning strategies in majority of cases (cave: robustness, positioning accuracy) – fixed oblique beam in the absence of clinical data...

30 Particle Therapy: fixed beam vs gantry ?

31 Thank you! http://www.so-schoen-ist-deutschland-im- herbst.de/cms/h/heidelberg/schoene-orte-a-z/heidelberg/dei- alte-bruecke-im-nebel-31.html http://www.welt.de/reise/staedtereisen/article11506464/Den-Advent-im- mittelalterlichen-Bern-geniessen.html

Download ppt "Clinical benefits: fixed beam line vs gantry? PD Dr. Alexandra Jensen, MSc mingham-Why-send-tourists-there.html."

Similar presentations

Dept of Radiation Oncology MGH

Dept of Radiation Oncology MGH
Collaboration UMC St Radboud - RISO

Collaboration UMC St Radboud - RISO
RapidArc plan verification using ArcCHECK™

RapidArc plan verification using ArcCHECK™
Experience, Expertise and a Commitment to Excellence™

Experience, Expertise and a Commitment to Excellence™
Anatomy-based MLC Field Optimization for the Treatment of Gynecologic Malignancies Myriam Bouchard M.D. Nadeau S, Germain I, Raymond P.E., Harel F, Beaulieu.

Anatomy-based MLC Field Optimization for the Treatment of Gynecologic Malignancies Myriam Bouchard M.D. Nadeau S, Germain I, Raymond P.E., Harel F, Beaulieu.
PAUL SCHERRER INSTITUT Future directions and current challenges of proton therapy Tony Lomax, Oxford, 2008 Future directions and current challenges of.

PAUL SCHERRER INSTITUT Future directions and current challenges of proton therapy Tony Lomax, Oxford, 2008 Future directions and current challenges of.
Targeting Issues For Proton Treatments Of The Prostate SJ Rosenthal Ph.D., JA Wolfgang Ph.D., Sashi Kollipara Department of Radiation Oncology Massachusetts.

Targeting Issues For Proton Treatments Of The Prostate SJ Rosenthal Ph.D., JA Wolfgang Ph.D., Sashi Kollipara Department of Radiation Oncology Massachusetts.
Some remaining questions in particle therapy radiation biology Bleddyn Jones University of Oxford 1. Gray Institute for Radiation Oncology & Biology 2.

Some remaining questions in particle therapy radiation biology Bleddyn Jones University of Oxford 1. Gray Institute for Radiation Oncology & Biology 2.
4-Dimensional Treatment Planning of Lung Tumors. Lung Cancer 1 out of 14 people will be diagnosed with lung cancer at some point in their life! 90% of.

4-Dimensional Treatment Planning of Lung Tumors. Lung Cancer 1 out of 14 people will be diagnosed with lung cancer at some point in their life! 90% of.
Update on FLUKA use at CNAO Giuseppe Magro (PhD Student) and Andrea Mairani (HIT and CNAO) Pavia, Dec 16, 2014.

Update on FLUKA use at CNAO Giuseppe Magro (PhD Student) and Andrea Mairani (HIT and CNAO) Pavia, Dec 16, 2014.
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.

The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Intensity Modulated Radiation Therapy (IMRT) for Breast Cancer

Intensity Modulated Radiation Therapy (IMRT) for Breast Cancer
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.

Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
Heavy Ion Tumor Therapy

Heavy Ion Tumor Therapy
A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.

A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.
Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.

Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.
The Skandion clinic, plans for the use of particle beams for radiation therapy in Sweden presented by Erik Grusell, medical radiation physicist Dept of.

The Skandion clinic, plans for the use of particle beams for radiation therapy in Sweden presented by Erik Grusell, medical radiation physicist Dept of.
Dr. Rico Liu Consultant, Department of Clinical Oncology, Queen Mary Hospital Honorary Clinical Associate Professor, Department of Clinical Oncology, The.

Dr. Rico Liu Consultant, Department of Clinical Oncology, Queen Mary Hospital Honorary Clinical Associate Professor, Department of Clinical Oncology, The.
The external beam radiotherapy and Image-guided radiotherapy (2)

The external beam radiotherapy and Image-guided radiotherapy (2)
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):

Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):

Similar presentations

Ads by Google